| [February 09, 2016] |
 |
Non-Hodgkin Lymphoma Therapeutics Pipeline Review, H2 2015 - 100+ Companies & Drug Profiles - Research and Markets
Research and Markets (http://www.researchandmarkets.com/research/g9wchv/nonhodgkin)
has announced the addition of the "Non-Hodgkin
Lymphoma - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Multiple Myeloma (Kahler Disease), complete with
comparative analysis at various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press
releases. It also reviews key players involved in the therapeutic
development for Non-Hodgkin Lymphoma and special features on late-stage
and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Non-Hodgkin Lymphoma Overview
-
Therapeutics Devlopment
-
Pipeline Products for Non-Hodgkin Lymphoma- Overview
-
Pipeline Products for Non-Hodgkin Lymphoma- Comparative Analysis
-
Non-Hodgkin Lymphoma- Therapeutics under Development by Companies
-
Non-Hodgkin Lymphoma- Therapeutics under Investigation by
Universities/Institutes
-
Non-Hodgkin Lymphoma- Pipeline Products Glance
-
Late Stage Products
-
Clinical Stage Products
-
Early Stage Products
-
Non-Hodgkin Lymphoma- Products under Development by Companies
-
Non-Hodgkin Lymphoma- Products under Investigation by
Universities/Institutes
-
Non-Hodgkin Lymphoma- Companies Involved in Therapeutics Development
Companies Mentioned
-
4SC AG
-
AB Science SA
-
AbbVie Inc.
-
Acetylon Pharmaceuticals, Inc.
-
Actelion Ltd
-
Actinium Pharmaceuticals, Inc.
-
ADC (News - Alert) Therapeutics Sarl
-
Affimed Therapeutics AG
-
Agilvax, Inc.
-
Allinky Biopharma
-
Altor BioScience Corporation
-
Amgen Inc.
-
Arbutus Biopharma Corporation
-
arGEN-X BV
-
Astellas Pharma Inc.
-
AstraZeneca Plc
-
Atara Biotherapeutics, Inc.
-
Bayer AG
-
Bellicum Pharmaceuticals, Inc.
-
BioAtla, LLC
-
BioInvent International AB
-
BioLineRx, Ltd.
-
Bionovis SA
-
BioSight Ltd.
-
Biothera, Inc.
-
Boehringer Ingelheim GmbH
-
Boston Biomedical, Inc.
-
Bristol-Myers Squibb Company
-
Calimmune, Inc.
-
Calithera Biosciences, Inc.
-
Celgene Corporation
-
Cell Medica Limited
-
Celltrion, Inc.
-
Cellular Biomedicine Group, Inc.
-
Celon Pharma Sp. z o.o.
For more information visit http://www.researchandmarkets.com/research/g9wchv/nonhodgkin
View source version on businesswire.com: http://www.businesswire.com/news/home/20160209006123/en/
[ Back To TMCnet.com's Homepage ]
|
